Lomitapide
Lomitapide
About this item
Full title
Lomitapide
Publisher
Cham: Springer International Publishing
Journal title
American journal of cardiovascular drugs : drugs, devices, and other interventions, 2011-10, Vol.11 (5), p.347-352
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Aegerion Pharmaceuticals is developing lomitapide, a small-molecule, microsomal triglyceride transfer protein (MTP) inhibitor, for the treatment of both familial and primary hypercholesterolemia. Oral, oncedaily lomitapide will be targeted at patients resistant to HMG-CoA reductase inhibitors (statins) either due to abnormalities in liver function...
Alternative Titles
Full title
Lomitapide
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_888389733
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_888389733
Other Identifiers
ISSN
1175-3277
E-ISSN
1179-187X
DOI
10.2165/11533560-000000000-00000
How to access this item
Log in as a Library member
